EFG International’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
8,891
+483
+6% +$63.6K 0.02% 409
2026
Q1
$1.17M Buy
8,408
+1,501
+22% +$210K 0.03% 384
2025
Q4
$848K Buy
+6,907
New +$839K 0.02% 398

Other funds holding GILD

EFG International's GILD Position: Q2 2026 in Review

EFG International increased its Gilead Sciences (GILD) stake by 5.7% in Q2 2026, buying an estimated $63.6K and bringing the position to 8,891 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #409.

EFG International first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.17M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • EFG International held 8,891 shares of Gilead Sciences worth $1.12M as of Q2 2026.
  • EFG International bought 483 Gilead Sciences shares in Q2 2026, an estimated $63.6K.
  • Gilead Sciences made up 0.02% of EFG International's portfolio in Q2 2026, its #409 holding.
  • EFG International first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • EFG International's Gilead Sciences position peaked at $1.17M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.